UnannouncedVCRaise

Filed before 2025Filed 3 August 2022

Ascribe Bioscience Inc. raised $3.18M

Ascribe Bioscience Inc., an agriculture company based in Ithaca, NY, raised $3.18M in a new equity round, according to a filing dated 3 August 2022.

Raises filed before 2025 are not checked for a public announcement.

Filed
3 August 2022
Round
Equity round
Amount sold
$3.18M
Offering size
$3.27M
Investors so far
7
Based in
Ithaca, NY
Website
ascribebio.com

Investors on the board

Firms come from the venture funds whose filings name a director of this company.

Who is on the board

1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.

Sign in with Google

How it compares

Larger than 23% of the 1,764 tracked raises with an amount filed in 2022.

Ascribe Bioscience Inc. in public filings

FiledFilingSoldRaise
15 Oct 2025New filing$15MAnother raise
7 Oct 2024New filing$2.15MAnother raise
3 Aug 2022New filing$3.18MThis raise
15 Sep 2021New filing$2.5MAnother raise

Everything on Ascribe Bioscience Inc.

More with Yield Lab on the board

  1. Hunting Land Rentals By Owner, Inc.$2.73MAnnounced8 Sep 2026 · Brainerd, MN
  2. Plastomics Inc.$7.11MFiled before 202517 Dec 2021 · St. Louis, MO
  3. Ecto, Inc.$7.21MFiled before 202519 Jul 2021 · Atlanta, GA
  4. Impetus Agriculture, Inc.$915KFiled before 202525 Jan 2021 · Saint Louis, MO

All 25 raises

Other unannounced rounds

  1. DVx Atomic Co.$18.5MUnannounced · 1 day16 Sep 2026 · Boston, MA
  2. Aperio Systems, Inc.$1.6MUnannounced · 1 day16 Sep 2026 · Boston, MA
  3. Twin Health, Inc.$59MUnannounced · 1 day16 Sep 2026 · Menlo Park, CA
  4. Scoring Factory AI Inc.$500KUnannounced · 2 days15 Sep 2026 · New York, NY
  5. Royal & Pelham, Inc.$5.4MUnannounced · 2 days15 Sep 2026 · New Orleans, LA
  6. SPECTRA Holdings US, Ltd.$2.5MUnannounced · 2 days15 Sep 2026 · Sandy Springs, GA

All unannounced rounds

Seen it announced?

Send the link and the check will look at it.